Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
35 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07111819 | Cervical Cancer Screening Via Self-sampling | completed | N/A | 1,000 | Nazarbayev UniversityOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07782801 | Creation and Implementation a Method for Breast Reconstruction After Radical Surgery Using Decellularized Xenomatrix in Combination With Lymphovenous Anastomosis in Breast Cancer. | active not recruiting | N/A | 60 | National Research Oncology and Transplantology Center, KazakhstanOTHER | 1 | Aug 28, 2026 |
| clinicaltrials |
| NCT07707986 | Safety of Topical Exosome-Containing Liquid in Healthy Volunteers for Future Surgical Wound Use(EV-MELSAFE) | not yet recruiting | Phase 1 | 10 | West Kazakhstan Marat Ospanov Medical UniversityOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT03456076 | A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer | active not recruiting | Phase 3 | 257 | Hoffmann-La RocheINDUSTRY | 27 | Jul 15, 2026 | clinicaltrials |
| NCT06509880 | Immunosurveillance for Metastatic Colorectal Cancer(ISMCC) | completed | Phase 2 / Phase 3 | 187 | MIPO ClinicOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06812858 | PD-1 Inhibitors Maintenance for cHL Post-autoHCT | recruiting | Phase 2 | 83 | St. Petersburg State Pavlov Medical UniversityOTHER | 2 | May 22, 2026 | clinicaltrials |
| NCT07593196 | HER2-positive Metastatic Breast Cancer in Kazakhstan | not yet recruiting | — | 240 | AstraZenecaINDUSTRY | 1 | May 18, 2026 | clinicaltrials |
| NCT03371017 | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer(IMpassion132) | completed | Phase 3 | 595 | Hoffmann-La RocheINDUSTRY | 28 | Nov 12, 2025 | clinicaltrials |
| NCT06952361 | Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients | completed | — | 107 | Ardak ArynovOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06784765 | Preventive Use of PIPAC in Locally Advanced Gastric Cancer. | recruiting | N/A | 160 | National Research Oncology and Transplantology Center, KazakhstanOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05229822 | Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction | completed | — | 150 | Karaganda Medical UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT03191786 | A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy(IPSOS) | completed | Phase 3 | 453 | Hoffmann-La RocheINDUSTRY | 24 | Oct 23, 2024 | clinicaltrials |
| NCT06397430 | Nutritional Support for Patients Operated for Malignant Tumors in HPD Zone | completed | N/A | 91 | Karaganda Medical UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT03225586 | Prospective Urban Rural Epidemiology Study(PURE) | recruiting | — | 200,000 | Population Health Research InstituteOTHER | 25 | Jan 31, 2024 | clinicaltrials |
| NCT06209229 | Role of Neutrophils and Electro-bioluminescence in the Rehabilitation(RNE) | completed | Phase 1 | 34 | MIPO ClinicOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT03494803 | Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC | withdrawn | — | 0 | HKGepitherapeuticsINDUSTRY | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03499678 | Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA | terminated | — | 81 | HKGepitherapeuticsINDUSTRY | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03480659 | Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC | terminated | — | 165 | HKGepitherapeuticsINDUSTRY | 1 | Dec 21, 2023 | clinicaltrials |
| NCT05090605 | The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population | completed | — | 700 | Asfendiyarov Kazakh National Medical UniversityOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05095155 | Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality | completed | — | 400 | Asfendiyarov Kazakh National Medical UniversityOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05721872 | Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 38 | Nazarbayev UniversityOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT04630327 | Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory | completed | — | 226 | Kazakh Medical University of Continuing EducationOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05011409 | Prevalence of Depression and Anxiety Among Breast Cancer Patients | completed | — | 162 | Kazakh Medical University of Continuing EducationOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT01774786 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer(JACOB) | completed | Phase 3 | 780 | Hoffmann-La RocheINDUSTRY | 32 | Dec 30, 2020 | clinicaltrials |
| NCT02788214 | Helicobacter Pylori Genome Project (HpGP) | terminated | — | 1,000 | National Cancer Institute (NCI)NIH | 53 | Dec 19, 2020 | clinicaltrials |
| NCT00341185 | Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing | completed | — | 2,997 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00480428 | Radiation Exposure and Thyroid Disease in Kazakhstan | completed | — | 117 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT03550482 | Oncoxin® and Quality of Life in Cancer Patients | completed | Phase 4 | 133 | Catalysis SLINDUSTRY | 2 | Jun 5, 2019 | clinicaltrials |
| NCT01933945 | Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib(OPTIMIS) | completed | — | 1,676 | BayerINDUSTRY | 31 | Nov 6, 2018 | clinicaltrials |
| NCT03446495 | An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer(Renaissance) | unknown | — | 60 | Suriya YessentayevaOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT00812175 | Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib(GIDEON) | completed | — | 3,371 | BayerINDUSTRY | 39 | Oct 17, 2016 | clinicaltrials |
| NCT01254279 | Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen | completed | Phase 3 | 984 | SanofiINDUSTRY | 29 | Jan 21, 2015 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials